Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/230662
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment |
Autor: | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso, Carlos CSIC | Palabras clave: | Breast cancer Antibody drug conjugates Antibody conjugate nanoparticles Nanomedicines Targeted delivery systems |
Fecha de publicación: | 21-ago-2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | International Journal of Molecular Sciences 21(17): 6018 (2020) | Resumen: | Breast cancer is the most common invasive tumor in women and the second leading cause of cancer-related death. Nanomedicine raises high expectations for millions of patients as it can provide better, more efficient, and affordable healthcare, and it has the potential to develop novel therapeutics for the treatment of solid tumors. In this regard, targeted therapies can be encapsulated into nanocarriers, and these nanovehicles are guided to the tumors through conjugation with antibodies—the so-called antibody-conjugated nanoparticles (ACNPs). ACNPs can preserve the chemical structure of drugs, deliver them in a controlled manner, and reduce toxicity. As certain breast cancer subtypes and indications have limited therapeutic options, this field provides hope for the future treatment of patients with difficult to treat breast cancers. In this review, we discuss the application of ACNPs for the treatment of this disease. Given the fact that ACNPs have shown clinical activity in this clinical setting, special emphasis on the role of the nanovehicles and their translation to the clinic is placed on the revision. | Descripción: | © 2020 by the authors | Versión del editor: | http://dx.doi.org/10.3390/ijms21176018 | URI: | http://hdl.handle.net/10261/230662 | DOI: | 10.3390/ijms21176018 | ISSN: | 1661-6596 | E-ISSN: | 1422-0067 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Antibody_Juan_PV_Art2020.pdf | 1,75 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
20
checked on 13-mar-2024
SCOPUSTM
Citations
49
checked on 12-abr-2024
WEB OF SCIENCETM
Citations
44
checked on 28-feb-2024
Page view(s)
98
checked on 19-abr-2024
Download(s)
323
checked on 19-abr-2024